Updated:
Invivo Partners
Invivo Partners is a firm that invests in early-stage healthcare companies. It analyzes and enhances portfolio companies using financial, technical, and...
Invivo Partners
Invivo Partners is a firm that invests in early-stage healthcare companies. It analyzes and enhances portfolio companies using financial, technical, and scientific methods. Founded in 2019 in Barcelona, Spain, Invivo Partners has made 23 investments, including a Series B - II investment in Arthex Biotech on September 17, 2025.
General information
Firm type
Private Equity
Year founded
2012
Location
Region
Europe
Country
Spain
City
Barcelona
Corporate office
Barcelona, Spain
Frequently asked questions
Does Invivo Partners participate in fund commitments or only direct deals?
Invivo Partners' documented investment approach focuses on direct equity investments into private companies. There is no public record of the firm making fund-of-funds commitments or acting as a limited partner in other venture capital vehicles. The firm's strategy descriptions consistently reference direct company-level investing activity.
What is Invivo Partners' geographic mandate?
The firm maintains its sole operational office in Barcelona and directs its investment activity toward private companies located in Spain. No secondary offices, international deal teams, or cross-border investment programs outside Spain have been disclosed through public filings or the firm's official communications.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: